Performance of an In-House Human Immunodeficiency Virus Type 1 Genotyping System for Assessment of Drug Resistance in Cuba
- Autores: Abrahantes Y, Aleman Y, Alvarez A, AM, Correa C, Fonseca C, K, Kour V, Perez J, Perez L, Schrooten, Soto Y, Van Laethem, Vandamme, Vinken L, Y
- Ano de Publicação: 2015
- Journal: PLoS One
- Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324769/
As commercial human immunodeficiency virus type 1 drug resistance assays are expensive, they are not commonly used in resource-limited settings. Hence, a more affordable in-house procedure was set up taking into account the specific epidemiological and economic circumstances of Cuba. The performance characteristics of the in-house assay were evaluated using clinical samples with various subtypes and resistance patterns
Ler mais